We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Telaprevir, Boceprevir May Become Trial Standard of Care for Hepatitis C
Telaprevir, Boceprevir May Become Trial Standard of Care for Hepatitis C
July 20, 2011
CHICAGO — Recently approved hepatitis C drugs have improved treatment so much that future clinical trials of drugs may have to be held to their standards, according to an FDA official.